These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 28781284

  • 1. [Diagnosis and treatment of TMA based on Japanese clinical guides].
    Wada H, Hasegawa K, Watanabe M.
    Rinsho Ketsueki; 2017; 58(7):849-856. PubMed ID: 28781284
    [Abstract] [Full Text] [Related]

  • 2. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG, Kirsztajn GM.
    J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
    [Abstract] [Full Text] [Related]

  • 3. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC, Cohney SJ, Kausman JY, Shortt J, Hughes PD, Wood EM, Isbel NM, de Malmanche T, Durkan A, Hissaria P, Blombery P, Barbour TD.
    Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
    [Abstract] [Full Text] [Related]

  • 4. Atypical hemolytic uremic syndrome (aHUS): making the diagnosis.
    Laurence J.
    Clin Adv Hematol Oncol; 2012 Oct; 10(10 Suppl 17):1-12. PubMed ID: 23187605
    [Abstract] [Full Text] [Related]

  • 5. Natural history of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Wada H, Matsumoto T, Yamashita Y.
    Semin Thromb Hemost; 2014 Nov; 40(8):866-73. PubMed ID: 25377323
    [Abstract] [Full Text] [Related]

  • 6. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM, Cugno M.
    Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
    [Abstract] [Full Text] [Related]

  • 7. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.
    Laurence J, Haller H, Mannucci PM, Nangaku M, Praga M, Rodriguez de Cordoba S.
    Clin Adv Hematol Oncol; 2016 Nov; 14 Suppl 11(11):2-15. PubMed ID: 27930620
    [Abstract] [Full Text] [Related]

  • 8. Thrombotic microangiopathies.
    Rosove MH.
    Semin Arthritis Rheum; 2014 Jun; 43(6):797-805. PubMed ID: 24360024
    [Abstract] [Full Text] [Related]

  • 9. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
    Williams LA, Marques MB, Education Committee of the Academy of Clinical Laboratory Physicians and Scientists.
    Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904
    [Abstract] [Full Text] [Related]

  • 10. Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli.
    Nakayama S, Hirashio S, Yorishima H, Doi T, Yoshida Y, Matsumoto M, Masaki T.
    CEN Case Rep; 2019 Nov; 8(4):266-270. PubMed ID: 31177384
    [Abstract] [Full Text] [Related]

  • 11. The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry.
    Hassan S, Westwood JP, Ellis D, Laing C, Mc Guckin S, Benjamin S, Scully M.
    Br J Haematol; 2015 Dec; 171(5):830-5. PubMed ID: 26359646
    [Abstract] [Full Text] [Related]

  • 12. [Diagnosis and management of thrombotic microangiopathies].
    Matsumoto M.
    Rinsho Ketsueki; 2015 Oct; 56(10):2092-9. PubMed ID: 26458449
    [Abstract] [Full Text] [Related]

  • 13. [The frontline of TMA management].
    Saito K, Matsumoto M.
    Rinsho Ketsueki; 2022 Oct; 63(5):463-470. PubMed ID: 35662172
    [Abstract] [Full Text] [Related]

  • 14. Microangiopathic Hemolytic Anemia in Pregnancy.
    Neave L, Scully M.
    Transfus Med Rev; 2018 Oct; 32(4):230-236. PubMed ID: 30177429
    [Abstract] [Full Text] [Related]

  • 15. HUS and TTP: traversing the disease and the age spectrum.
    Donadelli R, Sinha A, Bagga A, Noris M, Remuzzi G.
    Semin Nephrol; 2023 Jul; 43(4):151436. PubMed ID: 37949684
    [Abstract] [Full Text] [Related]

  • 16. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC, Cohney SJ, Kausman JY, Shortt J, Hughes PD, Wood EM, Isbel NM, de Malmanche T, Durkan A, Hissaria P, Blombery P, Barbour TD.
    Intern Med J; 2018 Jun; 48(6):624-636. PubMed ID: 29582550
    [Abstract] [Full Text] [Related]

  • 17. Thrombotic microangiopathies: from animal models to human disease and cure.
    Caprioli J, Remuzzi G, Noris M.
    Contrib Nephrol; 2011 Jun; 169():337-350. PubMed ID: 21252531
    [Abstract] [Full Text] [Related]

  • 18. Syndromes of Thrombotic Microangiopathy.
    Shatzel JJ, Taylor JA.
    Med Clin North Am; 2017 Mar; 101(2):395-415. PubMed ID: 28189178
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis and management of complement mediated thrombotic microangiopathies.
    Cataland SR, Wu HM.
    Blood Rev; 2014 Mar; 28(2):67-74. PubMed ID: 24534133
    [Abstract] [Full Text] [Related]

  • 20.
    Bhandari J, Rout P, Sedhai YR.
    ; 2024 01. PubMed ID: 32310498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.